Prediction of the aggressiveness of non-functional pancreatic neuroendocrine tumors based on the dual-tracer PET/CT

被引:22
|
作者
Majala, Susanna [1 ,2 ]
Seppanen, Hanna [3 ,4 ]
Kemppainen, Jukka [2 ,5 ]
Sundstrom, Jari [6 ]
Schalin-Jantti, Camilla [4 ,7 ]
Gullichsen, Risto [1 ]
Schildt, Jukka [8 ]
Mustonen, Harri [4 ,9 ]
Vesterinen, Tiina [10 ,11 ,12 ]
Arola, Johanna [10 ,11 ]
Kauhanen, Saila [1 ,2 ]
机构
[1] Turku Univ Hosp, Div Digest Surg & Urol, POB 52, FIN-20521 Turku, Finland
[2] Turku Univ Hosp, Turku PET Ctr, POB 52, FIN-20521 Turku, Finland
[3] Univ Helsinki, Fac Med, Translat Canc Med Res Program, Dept Abdominal Surg, POB 340, FIN-00029 Helsinki, Finland
[4] Helsinki Univ Hosp, POB 340, FIN-00029 Helsinki, Finland
[5] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, POB 52, FIN-20521 Turku, Finland
[6] Turku Univ Hosp, Dept Pathol, POB 52, FIN-20521 Turku, Finland
[7] Univ Helsinki, Abdominal Ctr, Dept Endocrinol, POB 340, FIN-00029 Helsinki, Finland
[8] Helsinki Univ Hosp, Dept Clin Physiol & Nucl Med, Haartmaninkatu 4, FIN-00029 Helsinki, Finland
[9] Univ Helsinki, Dept Surg, POB 340, FIN-00029 Helsinki, Finland
[10] Univ Helsinki, Dept Pathol, HUSLAB, POB 400, FIN-00029 Helsinki, Finland
[11] Helsinki Univ Hosp, POB 400, FIN-00029 Helsinki, Finland
[12] Univ Helsinki, HiLIFE, Inst Mol Med Finland, POB 20, FIN-00014 Helsinki, Finland
关键词
NF-PNET; F-18-FDG-PET/CT; Ga-68-DOTANOC-PET/CT; prospective study; surgical management; Ki-67; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; ENETS CONSENSUS GUIDELINES; F-18-FDG PET; GA-68-DOTANOC PET/CT; PROGNOSTIC VALUE; MANAGEMENT; SURVIVAL; TOMOGRAPHY; RESECTION; KI-67;
D O I
10.1186/s13550-019-0585-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background Predicting the aggressive behavior of non-functional pancreatic neuroendocrine tumors (NF-PNET) remains controversial. We wanted to explore, in a prospective setting, whether the diagnostic accuracy can be improved by dual-tracer functional imaging Ga-68-DOTANOC and F-18-FDG-PET/CT in patients with NF-PNETs. Methods Thirty-one patients with NF-PNET (90% asymptomatic) underwent PET-imaging with F-18-FDG and Ga-68-DOTANOC, followed by surgery (n = 20), an endoscopic ultrasonography and fine-needle biopsy (n = 2) or follow-up (n = 9). A focal activity on PET/CT greater than the background that could not be identified as physiological activity was considered to indicate tumor tissue. The imaging results were compared to histopathology. The mean follow-up time was 31.3 months. Results Thirty-one patients presented a total of 53 lesions (40 histologically confirmed) on PET/CT. Thirty patients had a Ga-68-DOTANOC-positive tumor (sensitivity 97%) and 10 patients had an F-18-FDG-positive tumor. In addition, one Ga-68-DOTANOC-negative patient was F-18-FDG-positive. F-18-FDG-PET/CT was positive in 19% (3/16) of the G1 tumors, 63% (5/8) of the G2 tumors and 1/1 of the well-differentiated G3 tumor. Ga-68-DOTANOC-PET/CT was positive in 94% of the G1 tumors, 100% of the G2 tumors and 1/1 of the well-differentiated G3 tumor. Two out of six (33%) of the patients with lymph node metastases (LN+) were F-18-FDG-positive. The F-18-FDG-PET/CT correlated with tumor Ki-67 (P = 0.021). Further, the Krenning score correlated with tumor Ki-67 (P = 0.013). F-18-FDG-positive tumors were significantly larger than the F-18-FDG-negative tumors (P = 0.012). F-18-FDG-PET/CT showed a positive predictive value of 78% in the detection of potentially aggressive tumors (G2, G3, or LN + PNETs); the negative predictive value was 69%. Conclusions F-18-FDG-PET/CT is useful to predict tumor grade but not the LN+ of NF-PNETs. Patients with F-18-FDG-avid NF-PNETs should be referred for surgery. The Ga-68-DOTANOC-PET/CT also has prognostic value since the Krenning score predicts the histopathological tumor grade.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Prediction of the aggressiveness of non-functional pancreatic neuroendocrine tumors based on the dual-tracer PET/CT
    Susanna Majala
    Hanna Seppänen
    Jukka Kemppainen
    Jari Sundström
    Camilla Schalin-Jäntti
    Risto Gullichsen
    Jukka Schildt
    Harri Mustonen
    Tiina Vesterinen
    Johanna Arola
    Saila Kauhanen
    EJNMMI Research, 9
  • [2] A nomogram to preoperatively predict the aggressiveness of non-functional pancreatic neuroendocrine tumors based on CT features
    Shen, Xiaoding
    Yang, Fan
    Jiang, Taiyan
    Zheng, Zhenjiang
    Chen, Yonghua
    Tan, Chunlu
    Ke, Nengwen
    Qiu, Jiajun
    Liu, Xubao
    Zhang, Hao
    Wang, Xing
    EUROPEAN JOURNAL OF RADIOLOGY, 2024, 171
  • [3] Dual-Tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT Scan and G1-G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Evaluation of 124 Nonmetastatic Resected Cases
    Paiella, Salvatore
    Landoni, Luca
    Tebaldi, Sarah
    Zuffante, Michele
    Salgarello, Matteo
    Cingarlini, Sara
    D'Onofrio, Mirko
    Parisi, Alice
    Deiro, Giacomo
    Manfrin, Erminia
    Bianchi, Beatrice
    Montagnini, Greta
    Crino, Stefano Francesco
    Bassi, Claudio
    Salvia, Roberto
    NEUROENDOCRINOLOGY, 2022, 112 (02) : 143 - 152
  • [4] The Surgical and Therapeutic Activities of Non-Functional Pancreatic Neuroendocrine Tumors at a High-Volume Institution
    Zhang, Wu-Hu
    Xu, Jun-Feng
    Hu, Yu-Heng
    Qin, Yi
    Chen, Jie
    Yu, Xian-Jun
    Xu, Xiao-Wu
    Ji, Shun-Rong
    CANCERS, 2023, 15 (07)
  • [5] Differentiation of atypical non-functional pancreatic neuroendocrine tumor and pancreatic ductal adenocarcinoma using CT based radiomics
    He, Ming
    Liu, Zhenyu
    Lin, Yusong
    Wan, Jianzhong
    Li, Juan
    Xu, Kai
    Wang, Yun
    Jin, Zhengyu
    Tian, Jie
    Xue, Huadan
    EUROPEAN JOURNAL OF RADIOLOGY, 2019, 117 : 102 - 111
  • [6] Predicting survival in non-functional pancreatic neuroendocrine tumours
    Tan, Qing-Quan
    Wang, Xing
    Yang, Le
    Chen, Yong-Hua
    Tan, Chun-Lu
    Ke, Neng-Wen
    Liu, Xu-Bao
    ANZ JOURNAL OF SURGERY, 2020, 90 (10) : 2026 - 2031
  • [7] Surveillance strategy for small asymptomatic non-functional pancreatic neuroendocrine tumors - a systematic review and meta-analysis
    Sallinen, Ville
    Le Large, Tessa Y. S.
    Galeev, Shamil
    Kovalenko, Zahar
    Tieftrunk, Elke
    Araujo, Raphael
    Ceyhan, Gueralp O.
    Gaujoux, Sebastien
    HPB, 2017, 19 (04) : 310 - 320
  • [8] Observational study of surgical resection in small non-functional pancreatic neuroendocrine tumors: AS SEER-based study
    Lin, Jiajing
    Huang, Heguang
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [9] Basing Treatment Strategy for Non-functional Pancreatic Neuroendocrine Tumors on Tumor Size
    Kishi, Yoji
    Shimada, Kazuaki
    Nara, Satoshi
    Esaki, Minoru
    Hiraoka, Nobuyoshi
    Kosuge, Tomoo
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (09) : 2882 - 2888
  • [10] Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management
    Cloyd, Jordan M.
    Poultsides, George A.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (32) : 9512 - 9525